Image: Colossal Biosciences
Someone better call Ben Stiller, because history could soon be coming back to life. This week, Texas-based startup Colossal Biosciences announced a key breakthrough in its quest to create replicas of the extinct wooly mammoth and reintroduce them to the Arctic tundra.
First things first: Colossal isn’t technically planning to bring back the wooly mammoth. While the genomes of several frozen mammoths have been sequenced, there are major gaps which prevent exact mammoth clones from being made.
So, what was the breakthrough? Colossal managed to successfully reprogram Asian elephant cells into a kind of stem cell that can turn into every other cell type. This process previously worked in humans, monkeys, and leopards – but had proven difficult to replicate in elephants due to their natural cancer resistance.
👀 Looking ahead… Colossal, which is currently valued at $1.5 billion, also has future plans to bring back the dodo bird and the Tasmanian tiger.
🤖💬 Anthropic, the Amazon-backed AI startup, launched a new chatbot called Claude 3 Opus that it says outperforms ChatGPT-4, Google’s Gemini, and other similar products.
🤖 Humanoid AI robot startup Figure has raised $675 million from Jeff Bezos, Nvidia, Chat GPT-maker OpenAI, Microsoft, and others, it announced yesterday.
Let's make our relationship official, no 💍 or elaborate proposal required. Learn and stay entertained, for free.👇
All of our news is 100% free and you can unsubscribe anytime; the quiz takes ~10 seconds to complete